Currently, the global epidemic continues to spread. According to a report by the Global Times on February 8, India’s Ambassador to Cambodia Bragarde stated that at the request of Cambodian Prime Minister Hun Sen, India has approved the emergency provision of 100,000 doses of new crown vaccine to Cambodia. Some media believe that India is expanding its "vaccine diplomacy" in an attempt to compete with China. As part of its "Vaccine Friendship Initiative", India has provided vaccines to countries including Myanmar, Bangladesh, Nepal, Sri Lanka and Maldives. At the same time, Cambodia is an important partner of China, and it is expected that China will provide Cambodia with 1 million doses of the new crown vaccine.
The media pointed out: In an attempt to get ahead of the competition with China, the Modi government has provided millions of doses of locally produced AstraZeneca vaccine to neighboring countries. Even the domestic vaccination campaign in India has just begun. . Indian Prime Minister Narendra Modi is using India's advantages as the world's largest producer of various vaccines to promote regional relations and restrain China's political and economic dominance. At the same time, the current number of confirmed cases of new crown in India ranks second in the world. India’s gains from vaccine diplomacy will be small, and it is very likely that it will not be able to achieve its true purpose because China has greater power. India lacks China's ability to provide loans and military equipment, so it cannot win the support of its neighbors like China.
The Chinese Ministry of Foreign Affairs has already responded to India's so-called "vaccine diplomacy" against China. Spokesperson Zhao Lijian clearly pointed out: The virus is the common enemy of mankind, and the top priority of the international community is to unite and fight the epidemic together. The new crown vaccine is a global public product. At present, there are many new coronary pneumonia vaccines on the market around the world. The choice of vaccine should be decided by each country. There should be no vicious competition on this issue, let alone the so-called "confrontation." We hope and welcome more countries to produce more safe and effective vaccines faster, provide them to more developing countries, and benefit more people.
Zhao Lijian emphasized that China is working hard to implement the declaration of the new crown vaccine as a global public product, conducting international vaccine cooperation in different ways with other countries, especially developing countries, and providing support and assistance within its capacity according to their needs. . We will continue to promote the equitable distribution and use of vaccines around the world,Strive to benefit more people.
.
